AR118641A1 - Compuestos, composiciones y métodos - Google Patents

Compuestos, composiciones y métodos

Info

Publication number
AR118641A1
AR118641A1 ARP200101008A ARP200101008A AR118641A1 AR 118641 A1 AR118641 A1 AR 118641A1 AR P200101008 A ARP200101008 A AR P200101008A AR P200101008 A ARP200101008 A AR P200101008A AR 118641 A1 AR118641 A1 AR 118641A1
Authority
AR
Argentina
Prior art keywords
alkyl
cycloalkyl
independently
heterocyclyl
alkylsulfonyl
Prior art date
Application number
ARP200101008A
Other languages
English (en)
Spanish (es)
Inventor
Zachary K Sweeney
Jianwen A Feng
Anthony A Estrada
Vicente Fidalgo Javier De
Original Assignee
Denali Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denali Therapeutics Inc filed Critical Denali Therapeutics Inc
Publication of AR118641A1 publication Critical patent/AR118641A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP200101008A 2019-04-11 2020-04-08 Compuestos, composiciones y métodos AR118641A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962832775P 2019-04-11 2019-04-11

Publications (1)

Publication Number Publication Date
AR118641A1 true AR118641A1 (es) 2021-10-20

Family

ID=72752101

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200101008A AR118641A1 (es) 2019-04-11 2020-04-08 Compuestos, composiciones y métodos

Country Status (19)

Country Link
US (1) US12358896B2 (cg-RX-API-DMAC7.html)
EP (1) EP3953348B1 (cg-RX-API-DMAC7.html)
JP (1) JP7623294B2 (cg-RX-API-DMAC7.html)
KR (1) KR102962366B1 (cg-RX-API-DMAC7.html)
CN (1) CN113939294A (cg-RX-API-DMAC7.html)
AR (1) AR118641A1 (cg-RX-API-DMAC7.html)
AU (1) AU2020272045B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021020027A2 (cg-RX-API-DMAC7.html)
CA (1) CA3136447A1 (cg-RX-API-DMAC7.html)
DK (1) DK3953348T3 (cg-RX-API-DMAC7.html)
EA (1) EA202192530A1 (cg-RX-API-DMAC7.html)
ES (1) ES3018383T3 (cg-RX-API-DMAC7.html)
IL (1) IL287120B2 (cg-RX-API-DMAC7.html)
MA (1) MA55624A (cg-RX-API-DMAC7.html)
MX (1) MX2021012392A (cg-RX-API-DMAC7.html)
SG (1) SG11202111058XA (cg-RX-API-DMAC7.html)
TW (1) TWI851710B (cg-RX-API-DMAC7.html)
WO (1) WO2020210684A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202107499B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3086182A1 (en) 2017-12-20 2019-06-27 Denali Therapeutics Inc. Process for the preparation of pyrimidinyl-4-aminopyrazole compounds
AU2021371697B2 (en) * 2020-10-29 2024-10-24 Suzhou Yabao Pharmaceutical R&D Co., Ltd. Substituted diarylamine compound, pharmaceutical composition thereof, preparation method therefor, and use thereof
CN116120291B (zh) * 2023-04-11 2023-06-30 英矽智能科技(上海)有限公司 吲唑类化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101566091B1 (ko) 2010-11-10 2015-11-04 에프. 호프만-라 로슈 아게 Lrrk2 조절제로서 피라졸 아미노피리미딘 유도체
PT3472153T (pt) * 2016-06-16 2021-12-31 Denali Therapeutics Inc Pirimidin-2-ilamino-1h-pirazóis como inibidores de lrrk2 para uso no tratamento de distúrbios neurodegenerativos
WO2018217946A1 (en) * 2017-05-24 2018-11-29 Denali Therapeutics Inc. Compounds, compositions and methods
CA3086182A1 (en) 2017-12-20 2019-06-27 Denali Therapeutics Inc. Process for the preparation of pyrimidinyl-4-aminopyrazole compounds

Also Published As

Publication number Publication date
ES3018383T3 (es) 2025-05-16
EP3953348B1 (en) 2024-12-18
CN113939294A (zh) 2022-01-14
AU2020272045A1 (en) 2021-10-28
IL287120B1 (en) 2025-02-01
BR112021020027A2 (pt) 2021-12-07
TWI851710B (zh) 2024-08-11
JP7623294B2 (ja) 2025-01-28
DK3953348T3 (da) 2025-03-17
WO2020210684A1 (en) 2020-10-15
JP2022526015A (ja) 2022-05-20
KR102962366B1 (ko) 2026-05-11
TW202104213A (zh) 2021-02-01
AU2020272045B2 (en) 2026-01-15
EP3953348A1 (en) 2022-02-16
MX2021012392A (es) 2021-11-12
CA3136447A1 (en) 2020-10-15
EA202192530A1 (ru) 2022-03-15
IL287120B2 (en) 2025-06-01
US20220220094A1 (en) 2022-07-14
EP3953348A4 (en) 2023-01-18
SG11202111058XA (en) 2021-11-29
ZA202107499B (en) 2022-06-29
IL287120A (en) 2021-12-01
KR20210151887A (ko) 2021-12-14
US12358896B2 (en) 2025-07-15
MA55624A (fr) 2022-02-16

Similar Documents

Publication Publication Date Title
AR127309A2 (es) Derivados de piridazinona
AR119698A2 (es) Compuesto amida n-urea sustituida derivado de aminoácido
PE20190329A1 (es) Compuestos moduladores de fxr (nr1h4)
AR110139A1 (es) COMPUESTOS MONO Y ESPIROCÍCLICOS QUE CONTIENEN CICLOBUTANO Y AZETIDINA COMO INHIBIDORES DE LA INTEGRINA aV
AR054035A1 (es) Derivados benzodioxano y benzodioxolano y uso de los mismos
AR088029A1 (es) Compuestos de pirimidina sustituidos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento del dolor, accidentes cerebrovasculares, epilepsia y otras enfermedades del sistema nervioso central
AR082152A1 (es) Derivados de n-(metilsulfonil)benzamida, composiciones farmaceuticas que los comprenden y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por la inhibicion de nav1.7
AR067757A1 (es) Derivados de imidazo[4,5-c]piridin-2-ona, composiciones farmaceuticas que los contienen, procedimiento para su preparacion y uso de los mismos como agentes antivirales.
AR092108A1 (es) Piridazina 1,4 disustituida, analogos de la misma y metodos para tratar las enfermedades relacionadas con deficiencia del smn
AR065354A1 (es) Derivados de 2-aminopirimidina, un metodo para su preparacion, una composicion farmaceutica que lo comprende y su uso en el tratamiento de enfermedades mediadas por el receptor de histamina h4.
AR100418A1 (es) Compuestos y composiciones para inducir condrogénesis
AR098666A1 (es) Compuestos de biarilacetamida y sus métodos de uso
AR092288A1 (es) Ligandos del receptor ep1
AR107042A1 (es) Inhibidores de la tirosina quinasa de bruton y métodos de su uso
PE20190504A1 (es) Moduladores del receptor nmda espiro-lactam y uso de los mismos
AR100810A1 (es) Inhibidores de fosfatidilinositol 3-quinasa
AR107321A1 (es) Compuestos antiproliferativos, y sus composiciones farmacéuticas y usos
AR088246A1 (es) Derivados de etinilo
AR100714A1 (es) Derivados de alquilo y arilo de compuestos de 1-oxa-4,9-diazaespiro undecano que tienen actividad multimodal contra el dolor
AR091534A1 (es) Derivados de sulfonamida y metodos de uso de los mismos para mejorar la farmacocinetica de un farmaco
AR120649A1 (es) Antagonistas del receptor de crf y métodos de uso
MX2021012248A (es) Polimorfos de voruciclib y metodos de elaboracion y uso de los mismos.
AR123543A1 (es) DERIVADOS DE 2-(3-PIRIDIN-2-IL-4-QUINOLIN-4-IL-PIRAZOL-1-IL)-ACETAMIDA COMO INHIBIDORES DEL RECEPTOR DEL FACTOR DE CRECIMIENTO TRANSFORMANTE b-1 / ALK5
AR109651A1 (es) Compuestos de piridina y pirazina como inhibidores de ripk2
AR099690A1 (es) Ureas asimétricas p-sustituidas como moduladoras de la actividad de ghrelina